Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Relapse remains the most common cause of treatment failure for patients with acute myeloid leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a grave prognosis. Multiple studies have identified the presence of measurable residual disease (MRD) assessed by flow cyt...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Dillon, Richard, Hills, Robert, Freeman, Sylvie, Potter, Nicola, Jovanovic, Jelena, Ivey, Adam, Kanda, Anju Shankar, Runglall, Manohursingh, Foot, Nicola, Valganon, Mikel, Khwaja, Asim, Cavenagh, Jamie, Smith, Matthew, Ommen, Hans Beier, Overgaard, Ulrik Malthe, Dennis, Mike, Knapper, Steven, Kaur, Harpreet, Taussig, David, Mehta, Priyanka, Raj, Kavita, Novitzky-Basso, Igor, Nikolousis, Emmanouil, Danby, Robert, Krishnamurthy, Pramila, Hill, Kate, Finnegan, Damian, Alimam, Samah, Hurst, Erin, Johnson, Peter, Khan, Anjum, Salim, Rahuman, Craddock, Charles, Spearing, Ruth, Gilkes, Amanda, Gale, Rosemary, Burnett, Alan, Russell, Nigel H., Grimwade, David
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Myeloid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059484/
https://ncbi.nlm.nih.gov/pubmed/31932839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002959
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares